Company Name

Industry

Location

Revenue

Employees

Ceva Biomune

Biotechnology

United States, Kansas

$500M to $1B

51-200

BioXcel

Biotechnology

United States, Connecticut

$250M to $500M

51-200

Biotechnology Innovation Organization

Biotechnology

United States, District of Columbia

$250M to $500M

51-200

Momenta Pharmaceuticals

Biotechnology

United States, Massachusetts

$250M to $500M

51-200

Progenity

Biotechnology

United States, California

$250M to $500M

51-200

Mascoma

Biotechnology

United States, New Hampshire

$250M to $500M

51-200

BioSharing Network

Biotechnology

United States, Oklahoma

$250M to $500M

51-200

ProteinSimple

Biotechnology

United States, California

$250M to $500M

51-200

Axcella

Biotechnology

United States, Massachusetts

$250M to $500M

51-200

Artel by Advanced Instruments

Biotechnology

United States, Maine

$250M to $500M

51-200

Vaxxinity

Biotechnology

United States, Florida

$250M to $500M

51-200

Detect

Biotechnology

United States, Connecticut

$250M to $500M

51-200

iTeos Therapeutics

Biotechnology

United States, Massachusetts

$250M to $500M

51-200

CGT Global

Biotechnology

United States, California

$250M to $500M

51-200

SDIX LLC - An OriGene Company

Biotechnology

United States, Delaware

$250M to $500M

51-200

Bruker Applied Mass Spectrometry

Biotechnology

United States, Massachusetts

$250M to $500M

51-200

Union Agener

Biotechnology

United States, Georgia

$250M to $500M

51-200

Biosearch Life, a Kerry Company

Biotechnology

United States, California

$250M to $500M

51-200

Aperiomics

Biotechnology

United States, Virginia

$250M to $500M

51-200

Vividion Therapeutics

Biotechnology

United States, California

$250M to $500M

51-200